Stroke RSS

Filtered By:
Source: Heart, Lung and Circulation
Countries: Australia Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 28 results found since Jan 2013.

Time Trends in Stroke Risk Management Among Patients With Atrial Fibrillation in Australia Between 2011 –2019
This study examined management among Australian patients between 2011 –2019.
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: K. Giskes, N. Lowres, J. Orchard, K. Hyun, C. Hespe, B. Freedman Source Type: research

Older People With Atrial Fibrillation and Hypertension Are at Higher Risk of Poor Blood Pressure Control in Australian Primary Care
This study explored factors that influence BP control in AF patients with hypertension managed in Australian primary care, with a focus on older age.
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: R. Trivedi, T. Shaw, C. Chow, L. Laranjo Source Type: research

Atrial Fibrillation (AF) Screening Within a Tertiary Hospital —A Baseline Study of Current Practice
This study aims to establish the current baseline of ECG practice within a hospital setting.
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: S. Mahendran, C. Chow, A. Thiagalingam Source Type: research

Rheumatic Heart Disease Echocardiogram Screening by Nonexperts: A Review
Rheumatic Heart Disease occurs when heart valves are damaged by Rheumatic Fever. Young First Nations Australians aged between 5 –14 years are at high risk of developing Rheumatic Fever. Complications of Rheumatic Heart Disease include atrial fibrillation, endocarditis, heart failure, and stroke. Early disease detection is essential as Acute Rheumatic Fever is easily treatable if detected early.
Source: Heart, Lung and Circulation - July 1, 2023 Category: Cardiology Authors: S. Stolic, O. Best, L. O'Malley, J. Elliott Source Type: research

Oral Anticoagulant Use in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Review of the Evidence With Recommendations for Australian Clinical Practice
Chronic kidney disease is common in patients with atrial fibrillation (AF) and is associated with heightened risks of stroke/systemic embolisation and bleeding. In this review we outline the evidence for AF stroke prevention in kidney disease, identify current knowledge gaps, and give recommendations for anticoagulation at various stages of chronic kidney disease.Overall, anticoagulation is underused. Warfarin use becomes increasingly difficult with advancing kidney disease, with difficulty maintaining international normalised ratio (INR) in therapeutic range, increased risk of intracranial and fatal bleeding compared to n...
Source: Heart, Lung and Circulation - November 3, 2022 Category: Cardiology Authors: Christopher Hammett, Sunil V. Badve, Peter G. Kerr, Huyen A. Tran, Benjamin K. Dundon, Sidney Lo, Andrew Wong, Joanne E. Joseph, Jenny Deague, Vlado Perkovic Tags: Review Source Type: research

Underusage of Oral Anticoagulation in Atrial Fibrillation: Can We Prevent More Strokes?
Atrial fibrillation (AF) is the most common sustained arrhythmia in Australia, affecting 2% of the population, and 6% of those over the age of 55 years [1]. The greatest contributor to morbidity and mortality in AF is its association with ischaemic stroke [2]. AF increases the risk of cardioembolic stroke five-fold, with an annual incidence of up to 7% [3]. There have been several validated tools developed to help individualise stroke risk, such as the CHADS2 [4], CHA2DS2-VASc [5], and more recently the CHA2DS2-VA score [6], all of which require the input of several vascular risk factors.
Source: Heart, Lung and Circulation - June 2, 2021 Category: Cardiology Authors: Karan Rao, Ravinay Bhindi Tags: Editorial Source Type: research

516 Non-Vitamin K Anticoagulation for Non-Valvular Atrial Fibrillation in Regional Australia
Non-vitamin K antagonist oral anticoagulants (NOACs) are the therapy of choice for stroke prevention in patients with non-valvular atrial fibrillation and at least one risk factor. The Illawarra-Shoalhaven region local health district provides health services for around 400,000 people. In regional centres, many AF patients are managed by GPs. The purpose of this study was to identify the proportion of patients with NVAF who were prescribed different NOACs as well as determine if the dosage follows current guidelines.
Source: Heart, Lung and Circulation - November 8, 2020 Category: Cardiology Authors: J. Moragues Source Type: research

692 Anticoagulation Prescription for Indigenous and Non-Indigenous Patients With Atrial Fibrillation in Central Australia
This study sought to compare anticoagulant prescribing practices in Indigenous and non-Indigenous Australians with AF in Central Australia.
Source: Heart, Lung and Circulation - November 8, 2020 Category: Cardiology Authors: N. Clarke, C. Gallagher, B. Pitman, S. Tu, N. Hanna-Rivero, N. Kangaharan, K. Roberts-Thomson, D. Lau, R. Mahajan, P. Sanders, C. Wong Source Type: research

414 The Diagnostic Value of Inpatient Transthoracic Echocardiography for Stroke and TIA
Australian guidelines for ischaemic stroke recommend echocardiography for select patients in whom stroke aetiology is unclear after initial investigations.1 We sought to identify whether inpatient echocardiograms for investigation of stroke/TIA aetiology were appropriately utilised according to this recommendation.
Source: Heart, Lung and Circulation - November 8, 2020 Category: Cardiology Authors: M. Maffey, S. Nguyen, S. Wahi Source Type: research

Predictors of Anticoagulation Use in Indigenous and Non-Indigenous Australians with Atrial Fibrillation
Prior studies have demonstrated that anticoagulation underutilisation for atrial fibrillation (AF) and elevated stroke risk is common. However, there is little data on factors associated with appropriate anticoagulation, particularly in Indigenous Australians who face a disproportionate burden of AF and stroke. We thus sought to determine factors associated with anticoagulation use in Australians with AF.
Source: Heart, Lung and Circulation - October 29, 2020 Category: Cardiology Authors: Simon Rocheleau, Celine Gallagher, Bradley M. Pitman, Samuel J. Tu, Nicole Hanna-Rivero, Nicholas Clarke, Dominik Linz, Jeroen M. Hendriks, Melissa E. Middeldorp, Rajiv Mahajan, Dennis H. Lau, Kurt C. Roberts-Thomson, Prashanthan Sanders, Christopher X. W Tags: Original Article Source Type: research

Anticoagulant Initiation During Hospital Admissions for Atrial Fibrillation in South-East Queensland, Australia
Anticoagulation reduces stroke risk in patients with atrial fibrillation (AF) but under-prescribing in eligible patients has been commonly reported. Introduction of the direct acting oral anticoagulants (DOACs) was considered to potentially improve prescribing due to increased anticoagulant options. At the time of release to the Australian market, there were limited studies investigating anticoagulant usage during hospitalisations for AF. Therefore, the aim of this study was to investigate prescribing of oral anticoagulants during hospitalisation admissions for AF during the time of DOAC introduction to the Australian market.
Source: Heart, Lung and Circulation - March 31, 2020 Category: Cardiology Authors: Iniya Rathinam, Shailendra Anoopkumar-Dukie, Tony Badrick, Trudy Teasdale, Nijole Bernaitis Tags: Original Article Source Type: research

Cardiac Rehabilitation and Secondary Prevention Roundtable: Australian Implementation and Research Priorities
Cardiovascular disease (CVD), including coronary heart disease (CHD) and stroke, is the leading cause of death and disease burden globally [1]. CVD resulted in>1.1 million hospitalisations in 2015-16, and incurs the highest level of health care sector expenditure in Australia (11-12% of total health expenditure) [2]. CHD accounts for the greatest single disease morbidity (>500,000 bed-days annually) and nearly one fifth of all deaths with a total cost of $1.14 billion annually [2]. Over 65,000 Australians experience an acute coronary event (heart attack or unstable angina) each year [3], and, importantly, around a third of...
Source: Heart, Lung and Circulation - February 28, 2020 Category: Cardiology Authors: Julie Redfern, Gemma Figtree, Clara Chow, Garry Jennings, Tom Briffa, Robyn Gallagher, Rachelle Foreman, on behalf of Roundtable Attendees Tags: Editorial Source Type: research

Quality of Warfarin Anticoagulation in Indigenous and Non-Indigenous Australians With Atrial Fibrillation
Studies have shown that suboptimal anticoagulation quality, as measured by time in therapeutic range (TTR), affects a significant percentage of patients with atrial fibrillation (AF). However, TTR has not been previously characterised in Indigenous Australians who experience a greater burden of AF and stroke.
Source: Heart, Lung and Circulation - November 27, 2019 Category: Cardiology Authors: Mau T. Nguyen, Celine Gallagher, Bradley M. Pitman, Mehrdad Emami, Kadhim Kadhim, Jeroen M. Hendriks, Melissa E. Middeldorp, Kurt C. Roberts-Thomson, Rajiv Mahajan, Dennis H. Lau, Prashanthan Sanders, Christopher X. Wong Tags: Original Article Source Type: research

Atrial Fibrillation and Indigenous Australians: A way Forward for Timely and Effective Screening and Treatment
Background: The leading cause of death for Indigenous Australians is cardiovascular disease, including stroke. Atrial Fibrillation (AF) increases stroke risk 5 –7 fold. Early detection and treatment of AF in Caucasians has proven feasible. Aim: To estimate AF prevalence in community settings and examine feasibility of using a handheld single-lead ECG device (iECG) for Indigenous Australians.
Source: Heart, Lung and Circulation - June 23, 2019 Category: Cardiology Authors: K. Gwynne, J. Gwynn, H. Finlayson, S. Hamilton, M. Lawrence, R. MacNiven, L. Neubeck, B. Rambaldini, R. Rodrigues, K. Taylor, S. Thompson, B. Freedman Tags: 514 Source Type: research

Pages: 1 2